Related Experiment Video
Updated: Aug 20, 2026

Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model
Published on: March 31, 2023
[Subcutaneously tunnelled cuffed venous hemodialysis catheters in chronic renal failure]
1Medizinische Klinik I, Klinikum Wetzlar-Braunfels. Martin.Brueck@hkw.med.uni-giessen.de
Insights
Subcutaneously tunnelled cuffed hemodialysis catheters offer safe and effective long-term vascular access, particularly for elderly patients or those with limited options. These catheters demonstrate a low complication rate and extended usability for hemodialysis patients.
Area of Science:
- Nephrology
- Vascular Surgery
- Medical Devices
Context:
- Increasing use of Silastic cuffed catheters for long-term hemodialysis access.
- Rising patient age and exhaustion of alternative vascular access sites necessitate reliable solutions.
- Experience with subcutaneously tunnelled cuffed hemodialysis catheters is reported.
Purpose:
- To evaluate the safety, feasibility, and complication rates of subcutaneously tunnelled cuffed hemodialysis catheters.
- To assess the long-term performance and efficacy of these catheters in a patient cohort.
- To determine the suitability of this access method for specific patient populations.
Summary:
- 258 catheters were placed in 203 patients (mean age 70) with a 100% initial success rate and 6% periprocedural complications.
- Median indwell time was 9 months with a 72% primary patency rate; inadequate flow occurred in 1/41 patient-months, resolved in 50% of cases.
- Bacteremia occurred at 1/16 patient-months, with catheter removal for infection/bacteremia at 1/73 patient-months; no bacterial endocarditis was observed.
Impact:
- Subcutaneously tunnelled cuffed venous hemodialysis catheters are safe and highly feasible.
- These catheters offer a low complication rate and long use-life.
- This access method is particularly beneficial for elderly patients, those with exhausted access sites, or failing arteriovenous fistulas.
Background:
Silastic cuffed catheters play an increasing role in providing long-term vascular access for hemodialysis. The reasons for this were related to increased patient age and an increased number of patients who had exhausted sites for vascular access. We report our experience with subcutaneously tunnelled cuffed hemodialysis catheters.
Method:
From May 1, 2001 to February 28, 2003, 258 consecutive hemodialysis catheters were placed in 203 patients (122 men, mean age 70 +/- 12 years) as access for hemodialysis (1.3 catheters/patient). Catheter implantation was explained to all patients and a protocol consent form was signed. The catheter was implanted via the internal jugular, subclavian or femoral vein and the correct final catheter position was determined fluoroscopically. Short and long-term catheter-associated complications were collected from the time of catheter insertion until a follow up of at least 6 months after implantation.
Results:
The mean duration of implantation procedure was 38 +/- 12 minutes with an initial clinical success rate of 100 % and a periprocedural complication rate of 6 %. The median catheter indwell time was 9 months with a primary patency rate of 72 % at the end of the follow-up. Inadequate flow rate < 200 ml/min was noted at one per 41 patient-months but sufficient blood flow was restored in 50 % of these patients with non- or semi-invasive interventions. Bacteremic episodes occurred at a rate of one episode per 16 patient-months. Catheter removal due to severe exit site infections or bacteremic episodes were necessary at one per 73 patient-months. There were no cases of bacterial endocarditis.
Conclusion:
Subcutaneously tunnelled cuffed venous hemodialysis catheters are a safe und highly feasible vascular access with a low complication rate and a long use-life especially for elder patients with limited life expectancy, exhausted sites for vascular access or in case of failing hemodialysis arteriovenous fistulas.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Cardiac Catheterization I: Pre-Procedure Overview
Venous Thrombosis III: Interprofessional Care

